| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S001250050535 |
| P698 | PubMed publication ID | 8858216 |
| P50 | author | Andrzej S. Krolewski | Q87809680 |
| P2093 | author name string | J H Warram | |
| M Quinn | |||
| M C Angelico | |||
| P2860 | cites work | The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group | Q27861088 |
| Linkage strategies for genetically complex traits. II. The power of affected relative pairs | Q35201348 | ||
| Molecular genetic approaches to the identification of genes involved in the development of nephropathy in insulin-dependent diabetes mellitus | Q35567599 | ||
| The changing natural history of nephropathy in type I diabetes | Q38520789 | ||
| Is diabetic nephropathy an inherited complication? | Q41109741 | ||
| Elevated blood pressure predicts the development of persistent proteinuria in the presence of poor glycemic control, in patients with type I diabetes | Q41286304 | ||
| Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy | Q41306582 | ||
| Familial aggregation of a disease consequent upon correlation between relatives in a risk factor measured on a continuous scale | Q44325842 | ||
| Diabetic nephropathy in type 1 (insulin-dependent) diabetes: An epidemiological study | Q50584833 | ||
| On the measurement of susceptibility in epidemiologic studies. | Q52247904 | ||
| Predisposition to hypertension: risk factor for nephropathy and hypertension in IDDM | Q52423360 | ||
| Can familial aggregation of disease be explained by familial aggregation of environmental risk factors? | Q52570640 | ||
| Genetic factors in diabetic nephropathy | Q69706511 | ||
| Risk factors for development of microalbuminuria in insulin dependent diabetic patients: a cohort study. Microalbuminuria Collaborative Study Group, United Kingdom | Q70732297 | ||
| Parent-offspring and sibling lipid and lipoprotein associations during and after sharing of household environments: the Princeton school district family study | Q72038055 | ||
| Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus | Q72136248 | ||
| Persistent microalbuminuria in adolescents with type I (insulin-dependent) diabetes mellitus is associated to early rather than late puberty. Results of a prospective longitudinal study | Q72194307 | ||
| Hypercholesterolemia--a determinant of renal function loss and deaths in IDDM patients with nephropathy | Q72365773 | ||
| Predictors of microalbuminuria in individuals with IDDM. Pittsburgh Epidemiology of Diabetes Complications Study | Q72678721 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | patient | Q181600 |
| diabetic nephropathy | Q1129105 | ||
| P304 | page(s) | 940-945 | |
| P577 | publication date | 1996-08-01 | |
| P1433 | published in | Diabetologia | Q5270140 |
| P1476 | title | Familial factors determine the development of diabetic nephropathy in patients with IDDM. | |
| P478 | volume | 39 |
| Q35917504 | A 4.1-Mb congenic region of Rf-4 contributes to glomerular permeability |
| Q52804042 | A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes. |
| Q28943287 | A genome-wide association study for diabetic nephropathy genes in African Americans |
| Q39784426 | A single nucleotide polymorphism in KCNQ1 is associated with susceptibility to diabetic nephropathy in japanese subjects with type 2 diabetes. |
| Q30978054 | A single nucleotide polymorphism within the acetyl-coenzyme A carboxylase beta gene is associated with proteinuria in patients with type 2 diabetes |
| Q33783045 | A systematic review and meta-analysis of genetic association studies for the role of inflammation and the immune system in diabetic nephropathy |
| Q60300866 | A variant within the FTO confers susceptibility to diabetic nephropathy in Japanese patients with type 2 diabetes |
| Q59489250 | Aldosterone synthase (CYP11B2) -344T/C polymorphism is not associated with the initiation and progression of diabetic nephropathy in Caucasian Type 1 diabetic patients |
| Q30417141 | An intergenic region on chromosome 13q33.3 is associated with the susceptibility to kidney disease in type 1 and 2 diabetes |
| Q57306280 | Analysis of the association between diabetic nephropathy and polymorphisms in the aldose reductase gene in Type 1 and Type 2 diabetes mellitus |
| Q24801926 | Apolipoprotein E gene polymorphism is not a strong risk factor for diabetic nephropathy and retinopathy in Type I diabetes: case-control study |
| Q36262386 | Assessing genetic susceptibility to diabetic nephropathy |
| Q40463282 | Association Between Blood Pressure and Adverse Renal Events in Type 1 Diabetes. |
| Q41611035 | Association between Osteopontin Promoter Gene Polymorphisms and Haplotypes with Risk of Diabetic Nephropathy |
| Q44398252 | Association between polymorphisms of the atrial natriuretic peptide gene and proteinuria: a population-based study |
| Q42126412 | Association between single nucleotide polymorphisms within genes encoding sirtuin families and diabetic nephropathy in Japanese subjects with type 2 diabetes |
| Q45245187 | Association between the GLUT1 gene polymorphism and the risk of diabetic nephropathy: a meta-analysis |
| Q39893122 | Association of aldosterone synthase (CYP11B2) -344 T/C polymorphism with diabetic nephropathy: A meta-analysis |
| Q37156204 | Association of genetic variants at 3q22 with nephropathy in patients with type 1 diabetes mellitus |
| Q42672940 | Association of kidney structure-related gene variants with type 2 diabetes-attributed end-stage kidney disease in African Americans |
| Q35004388 | Association of variants in the carnosine peptidase 1 gene (CNDP1) with diabetic nephropathy in American Indians |
| Q36109264 | Association testing of previously reported variants in a large case-control meta-analysis of diabetic nephropathy |
| Q64936514 | Associations between the HaeIII Single Nucleotide Polymorphism in the SLC2A1 Gene and Diabetic Nephropathy in Korean Patients with Type 2 Diabetes Mellitus. |
| Q45122689 | Cellular basis of diabetic nephropathy: III. In vitro GLUT1 mRNA expression and risk of diabetic nephropathy in type 1 diabetic patients |
| Q41123351 | Combination of Angiotensin Converting Enzyme Insertion/Deletion (I/D) (rs4646994) and VEGF Polymorphism (+405G/C; rs2010963) Synergistically Associated With the Development, of Albuminuria in Iranian Patients With Type 2 Diabetes. |
| Q30434280 | Confirmation of genetic associations at ELMO1 in the GoKinD collection supports its role as a susceptibility gene in diabetic nephropathy |
| Q37365616 | Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group |
| Q35627938 | Cost-effective strategies in the prevention of diabetic nephropathy |
| Q45072634 | Diabetic Microvascular Disease: An Endocrine Society Scientific Statement |
| Q44664522 | Diabetic complications. Micro and macroangiopathic end-organ damage |
| Q59220162 | Diabetic nephropathy |
| Q34774837 | Diabetic nephropathy in a sibling and albuminuria predict early GFR decline: a prospective cohort study |
| Q36973440 | Diabetic nephropathy in children and adolescents |
| Q59150371 | ELMO1 variants and susceptibility to diabetic nephropathy in American Indians |
| Q37689847 | Effects of Apolipoprotein E Isoforms in Diabetic Nephropathy of Chinese Type 2 Diabetic Patients. |
| Q38105995 | Emerging roles for miRNAs in the development, diagnosis, and treatment of diabetic nephropathy |
| Q47412518 | Epigenetics in diabetic nephropathy, immunity and metabolism. |
| Q36842676 | Exclusion of polymorphisms in carnosinase genes (CNDP1 and CNDP2) as a cause of diabetic nephropathy in type 1 diabetes: results of large case-control and follow-up studies |
| Q34292853 | Familial clustering of ESRD in the Norwegian population |
| Q30420116 | Family-based association analysis confirms the role of the chromosome 9q21.32 locus in the susceptibility of diabetic nephropathy |
| Q33883432 | Functional characterization of the plasmacytoma variant translocation 1 gene (PVT1) in diabetic nephropathy |
| Q36906421 | G/T substitution in intron 1 of the UNC13B gene is associated with increased risk of nephropathy in patients with type 1 diabetes |
| Q36787564 | Gene discovery in diabetic nephropathy |
| Q30422127 | Gene expression differences in skin fibroblasts in identical twins discordant for type 1 diabetes |
| Q56334468 | Genetic Contribution to Risk for Diabetic Kidney Disease |
| Q34153165 | Genetic associations in diabetic nephropathy: a meta-analysis |
| Q51914338 | Genetic diversity of the apolipoprotein E gene and diabetic nephropathy: a meta-analysis. |
| Q33416406 | Genetic polymorphisms and the risk of accelerated renal function decline in women |
| Q51920914 | Genetic risk factors for diabetic nephropathy on chromosomes 6p and 7q identified by the set-association approach. |
| Q36262395 | Genetic susceptibility to type 2 diabetic nephropathy in human and animal models |
| Q37310058 | Genetic variant in the promoter of connective tissue growth factor gene confers susceptibility to nephropathy in type 1 diabetes |
| Q35107546 | Genetic variation at the ACE gene is associated with persistent microalbuminuria and severe nephropathy in type 1 diabetes: the DCCT/EDIC Genetics Study |
| Q85019990 | Genetics of Diabetes Complications |
| Q37406607 | Genetics of Kidneys in Diabetes (GoKinD) study: a genetics collection available for identifying genetic susceptibility factors for diabetic nephropathy in type 1 diabetes |
| Q85210614 | Genetics of diabetes complications |
| Q35087689 | Genetics of diabetic nephropathy in the Pima Indians |
| Q90182401 | Genome-Wide Association Study of Diabetic Kidney Disease Highlights Biology Involved in Glomerular Basement Membrane Collagen |
| Q33650362 | Genome-wide DNA methylation analysis for diabetic nephropathy in type 1 diabetes mellitus |
| Q30435965 | Genome-wide association scan for diabetic nephropathy susceptibility genes in type 1 diabetes |
| Q57591416 | Genome-wide association study of urinary albumin excretion rate in patients with type 1 diabetes |
| Q46728081 | Genome-wide linkage scans for renal function and albuminuria in Type 2 diabetes mellitus: the Diabetes Heart Study |
| Q36646597 | High Elmo1 expression aggravates and low Elmo1 expression prevents diabetic nephropathy |
| Q36842660 | High-density single nucleotide polymorphism genome-wide linkage scan for susceptibility genes for diabetic nephropathy in type 1 diabetes: discordant sibpair approach |
| Q36785588 | Histopathology of diabetic nephropathy |
| Q27000709 | Human genetics of diabetic vascular complications |
| Q44435407 | In situ protein Kinase C activity is increased in cultured fibroblasts from Type 1 diabetic patients with nephropathy |
| Q90671190 | Inflammation and Immunity Pathways Regulate Genetic Susceptibility to Diabetic Nephropathy |
| Q26823352 | Insights into the genetic architecture of diabetic nephropathy |
| Q33761745 | Insights to the genetics of diabetic nephropathy through a genome-wide association study of the GoKinD collection |
| Q24200376 | Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus |
| Q91671449 | Interaction between ELMO1 gene polymorphisms and environment factors on susceptibility to diabetic nephropathy in Chinese Han population |
| Q33852450 | Is it possible to predict diabetic kidney disease? |
| Q37403354 | Knockdown of glyoxalase 1 mimics diabetic nephropathy in nondiabetic mice |
| Q36204486 | Linkage Analysis of Genomic Regions Contributing to the Expression of Type 1 Diabetes Microvascular Complications and Interaction with HLA |
| Q81099317 | Methylenetetrahydrofolate reductase gene polymorphism as a risk factor for diabetic nephropathy: a meta-analysis |
| Q37458886 | Mitigating micro-and macro-vascular complications of diabetes beginning in adolescence. |
| Q47735079 | Modelling diabetic nephropathy in mice. |
| Q37127488 | Multiple superoxide dismutase 1/splicing factor serine alanine 15 variants are associated with the development and progression of diabetic nephropathy: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complicat |
| Q36938570 | Navigating pathways affecting type 1 diabetic kidney disease |
| Q24301446 | Nephropathy in type 1 diabetes is diminished in carriers of HLA-DRB1*04: the genetics of kidneys in diabetes (GoKinD) study |
| Q37995591 | Network-centric Analysis of Genetic Predisposition in Diabetic Nephropathy. |
| Q37598306 | New insights into molecular mechanisms of diabetic kidney disease |
| Q41690327 | Novel Genetic Actors of Diabetes-Associated Microvascular Complications: Retinopathy, Kidney Disease and Neuropathy |
| Q34016561 | Novel susceptibility locus at 22q11 for diabetic nephropathy in type 1 diabetes |
| Q54708979 | Paraoxonase 1 Gln/Arg polymorphism is associated with the risk of microangiopathy in Type 2 diabetes mellitus. |
| Q45150525 | Peroxisome proliferator-activated receptor gamma gene polymorphism is associated with serum triglyceride levels and body mass index in Japanese type 2 diabetic patients. |
| Q46509027 | Polymorphism of the solute carrier family 12 (sodium/chloride transporters) member 3, SLC12A3, gene at exon 23 (+78G/A: Arg913Gln) is associated with elevation of urinary albumin excretion in Japanese patients with type 2 diabetes: a 10-year longitu |
| Q38299503 | Polymorphisms in the 3' UTR in the neurocalcin delta gene affect mRNA stability, and confer susceptibility to diabetic nephropathy |
| Q33886401 | Predicting diabetic nephropathy using a multifactorial genetic model |
| Q31895128 | Predisposition to nephropathy in Polynesians is associated with family history of renal disease, not diabetes mellitus. |
| Q37668647 | Prevalence of diabetic nephropathy among Type 2 diabetic patients in some of the Arab countries |
| Q36977349 | Renal lesions predict progression of diabetic nephropathy in type 1 diabetes |
| Q46041621 | Repeat polymorphisms in the Homo sapiens heme oxygenase-1 gene in diabetic and idiopathic gastroparesis. |
| Q34024371 | Replication study for the association between four Loci identified by a genome-wide association study on European American subjects with type 1 diabetes and susceptibility to diabetic nephropathy in Japanese subjects with type 2 diabetes |
| Q44585580 | Replication study for the association of 3 SNP loci identified in a genome-wide association study for diabetic nephropathy in European type 1 diabetes with diabetic nephropathy in Japanese patients with type 2 diabetes |
| Q30830157 | Resequencing of genes for transforming growth factor beta1 (TGFB1) type 1 and 2 receptors (TGFBR1, TGFBR2), and association analysis of variants with diabetic nephropathy |
| Q60544447 | Resequencing of the characterised CTGF gene to identify novel or known variants, and analysis of their association with diabetic nephropathy |
| Q35087673 | Risk predictors in patients with diabetic nephropathy |
| Q89141117 | SUMO4 163 G>A variation is associated with kidney disease in Indian subjects with type 2 diabetes |
| Q73922985 | Synergistic effect of angiotensin II type 1 receptor genotype and poor glycaemic control on risk of nephropathy in IDDM |
| Q36293641 | TOX and CDKN2A/B Gene Polymorphisms Are Associated with Type 2 Diabetes in Han Chinese |
| Q37733530 | The Association of a Genetic Variant in SCAF8-CNKSR3 with Diabetic Kidney Disease and Diabetic Retinopathy in a Chinese Population. |
| Q64121353 | The Familiality of Rapid Renal Decline in Diabetes |
| Q54688757 | The TGF-beta 1 gene codon 10 polymorphism contributes to the genetic predisposition to nephropathy in Type 1 diabetes. |
| Q57788997 | The contribution of genetic variants of SLC2A1 gene in T2DM and T2DM-nephropathy: association study and meta-analysis |
| Q38396875 | The genetics of diabetic complications |
| Q37590421 | The genetics of diabetic nephropathy. |
| Q33913749 | The influence of carnosinase gene polymorphisms on diabetic nephropathy risk in African-Americans |
| Q48552318 | The kidney in diabetes: dynamic pathways of injury and repair. The Camillo Golgi Lecture 2007. |
| Q33588129 | The natural course of microalbuminuria among African Americans with type 2 diabetes: a 3-year study |
| Q42976561 | Type 2 diabetes mellitus and its complications: from the molecular biology to the clinical practice |
| Q42589526 | Using discordant sib pairs to map loci for qualitative traits with high sibling recurrence risk. |
| Q36538396 | What is the mechanism of microalbuminuria in diabetes: a role for the glomerular endothelium? |
Search more.